Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Deals & Financings

GV20 Oncotherapy Closes Series B for Genomics/AI-based mAb Portfolio 
BeiGene and Bristol-Myers in Fight over China Abraxane Distribution Deal
Hansoh Signs $456 Million Agreement for siRNA Products from OliX Pharma
BioNova Acquires Rights to CD74 Candidate from Sutro in $204 Million Deal
Hangzhou's Sciwind Closes $70 Million Series C for Metabolic Therapies
ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China